Skip to content
Canadian Non-Sterile Compounding Standards: Continuing Education for Pharmacy Professionals
This 6.0-hour (0.6 CEUs) knowledge-based home study is designed for pharmacists and pharmacy technicians involved in non-sterile compounding who want a clear understanding of Canadian regulatory standards and how they apply to day-to-day practice. The course focuses on reviewing current standards and best practices used to evaluate compounding procedures, develop pharmacy protocols, and apply appropriate quality controls to support the safety and effectiveness of non-sterile preparations for both patients and staff.
Documents Covered
-
Guidance on Pharmacy Compounding of Non-Sterile Preparations
-
Model Standards for Pharmacy Compounding of Non-Sterile Preparations
-
Printable and fillable forms to support documentation and recordkeeping
Topics Covered
-
Canadian regulatory guidelines and non-sterile compounding standards
-
Identifying risks and gaps in current compounding practices
-
Requirements for different levels of non-sterile compounding
-
Facility, equipment, and documentation expectations
-
Product and preparation requirements
-
Additional considerations for Level C non-sterile compounding
Who This Home Study Is For
-
Pharmacists involved in non-sterile compounding
-
Pharmacy technicians supporting compounding activities
-
Pharmacy professionals looking for a clearer understanding of Canadian non-sterile compounding standards
Review Canadian non-sterile compounding standards and understand how regulatory expectations apply to everyday pharmacy practice.
What participants said:
- “This course provided a very thorough and succinct explanation of all relevant information needed to safely implement compounding into the pharmacy workflow.”
- “The instructor very clearly explained these concepts in a well-organized manner for the audience to comprehend.”
- “The session provided a clear overview of current guidelines, easy access to commonly used compounding resources, and practical checklists that support safe compounding practices.”
Registration is below
Note: It is not necessary to create a Lecture Panda account to register for this home study.
Important note for Canadian participants:
Participants who are not receiving ACPE credit, including Canadian learners whose provincial regulatory bodies may not accept ACPE-accredited activities, will receive a Certificate of Completion upon successful completion of the post-test and evaluation. Certificates may be downloaded for personal records. Canadian pharmacists and pharmacy technicians are encouraged to confirm with their provincial college whether ACPE-accredited activities or certificates of completion meet their continuing competency requirements.
The American College of Apothecaries (ACA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACA has accredited this knowledge-based program for 6 contact hours (0.6 CEUs) of continuing education credit for pharmacists and pharmacy technicians.
The American College of Apothecaries (ACA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACA has accredited this knowledge/application-based program for 15 contact hours (1.5 CEUs) of continuing education credit for pharmacists and pharmacy technicians.
Register of Historic Places and is world-famous for its five resident Mallard ducks, who march daily through the lobby at 11am and 5pm.
Martha M. Rumore, PharmD, Esq, MS, LLM, FAPhA is a pharmacist-attorney in Frier Levitt’s Life Sciences Department. She is also a registered patent attorney and leads the firm’s Intellectual property team. She has broad and in-depth healthcare and regulatory experience. Her practice focuses on intellectual property (patents, trademarks, copyrights, trade secrets) and healthcare law, Food, Drug, Device & Cosmetic law (all facets-483s to clinical trials to registrations and product approval), pharmacy law and regulatory issues, 503A/503B compounding, Board of Pharmacy (licensing and disciplinary matters), PBM audits, and DSCSA supply chain compliance. Dr. Rumore has over 25 years of health-system, pharmaceutical industry, and law firm experience in the area of Food, Drug & Cosmetic Law, and pharmaceutical intellectual property Dr. Rumore is fluent in cGMPs, GCPs, writing and reviewing Clinical Trial Agreements (CTAs), Investigator brochures, manuscripts, labeling & advertising review, NDAs, study reports, and documents for regulatory submissions. She often prepares legal memoranda on healthcare/FDA matters and conducts Mock State Board of Pharmacy and FDA inspections for compounding pharmacies. Dr. Rumore has practiced both pharmacy and law. She has actual experience as a compounding pharmacist. She regularly counsels on Section 503A and state-specific compounding requirements, assesses compounding practices for state and federal regulatory compliance, including USP 797/795/800, medical necessity documentation, advertising & promotion, reimbursement issues, infrastructure, and preparing compounding policies and procedures that provide clear guidelines, standards, and training for staff. Previously, she was at the Director level in Drug Regulatory Affairs/Compliance in the pharmaceutical industry and hospital pharmacy. She taught Pharmacy Law, Drug Regulatory Affairs, and Food Drug & Cosmetic Law at several New York Colleges of Pharmacy and currently teaches Food, Drug & Cosmetic Law at Maurice A. Deane School of Law at Hofstra University. She is a frequent lecturer and has over 200 publications and presentations.
